04.08.2021 | Insight | Jeff Price
How We Beat the Heat in Blow-Fill-Seal
BFS begins with heating resin to roughly 180 degrees C to form a container, but there are powerful techniques to keep its liquid contents cool
Archive
Author: ewalker
03.03.2021 | BFS Manufacturing | Insight | Jeff Price
The Heat Factor: Why It Matters in Blow-Fill-Seal
Heat is an inherent part of the process when using aseptic Blow-Fill-Seal packaging, but many sterile pharmaceutical liquids are heat-sensitive —and therein lies the challenge.
02.09.2021 | COVID-19 | Insight | Michael Free
COVID-19: 3 Strategies to Defend Health as a Shared value
Better science education, more consistent health agency funding, and more international cooperation will help ensure a healthier world.
(Part 4 of a 4-Part Series)
02.08.2021 | COVID-19 | Insight | Michael Free
COVID-19: 3 Reasons Why Health is a Shared Value
The global pandemic is a universal danger, and it teaches us
that health is a shared value, requiring strong “health defense”
(Part 3 of a 4-part series)
01.08.2021 | COVID-19 | Insight | Michael Free
COVID-19: A Sneaky Virus
The coronavirus pandemic is hard to get a handle on because mortality varies with age, and the virus “hides” in seemingly healthy people.
(Part 2 of a 4-part series)
01.06.2021 | COVID-19 | Insight | Michael Free
COVID-19: A Few Key Numbers
Today’s pandemic is far from the largest in human history,
but various metrics reveal COVID-19’s lethal nature.
(Part 1 of a 4-part series)
12.23.2020 | Beth Totin | Insight | Prefilled Syringes
Prefilled Syringes: Why I’m an Optimist
Beth Totin, Chief Commercial Officer, discusses why we can now have all of the advantages of PFS, with virtually none of the drawbacks.
(Part 3 of a 3-part series)
12.21.2020 | Beth Totin | Insight | Prefilled Syringes
Prefilled Syringes: Yes, There Are a Few Challenges
Beth Totin, Chief Commercial Officer, goes into the challenges of PFS.
(Part 2 of a 3-part series)
12.11.2020 | Beth Totin | Insight | Prefilled Syringes
Prefilled Syringes: Rapid Growth Expected to Continue
Beth Totin, Chief Commercial Officer, explains why.
(Part 1 of a 3-part series)